Net sales rose slightly in Q3 but fell 11% for the first nine months, with operating losses deepening and equity turning negative. Urgent capital needs and a public takeover highlight a critical period for SARSYS.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.